Genesis Pharmaceuticals Enterprises, Inc. reported that it booked $12 million in new orders at the 43rd Annual New Drugs Conference sponsored by China Health Tech Forum 2008. Genesis will deliver the products over the next 12 months to more than 800 wholesale distributors. Genesis also said that more than 60% of the orders were for its newest product, Radix Isatidis Disperable Tablets, a nonprescription TCM treatment for flu. More details...

Stock Symbols: (OTCBB: GNPH)